Cisplatin induces renal expression of P-glycoprorein and canalicular multispecific organic anion transporter

American Journal of Physiology - Renal Physiology

Volumn 277, Issue 6 46-6, 1999, Pages

  Demeule, Michel ^b   Brossard, Mathieu ^b   Béliveau, Richard ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b NONE

Author keywords

Mrp2; Multidrug resistance; Renal brush border membranes

Indexed keywords

CISPLATIN; GLYCOPROTEIN P; M PROTEIN; MULTIDRUG RESISTANCE PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANION TRANSPORT; ARTICLE; KIDNEY TUBULE EPITHELIUM; MULTIDRUG RESISTANCE; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; TISSUE DISTRIBUTION;

EID: 0033373863     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Allan, S. G., and J. F. Smyth. Small intestinal mucosal toxicity of cis-platinum-comparison of toxicity with platinum analogues and dexamethasone. Br. J. Cancer 53: 355-360, 1986.
2. Booth, A. G., and A. J. Kenny. A rapid method for the preparation of microvilli from rabbit kidney. Biochem. J. 142: 575-581, 1974.
3. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
4. Chaudhary, P. M., and I. B. Roninson. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. Natl. Cancer Inst. 85: 632-639, 1993.
5. Cordon-Cardo, C., J. P. O'Brien, D. Casals, L. Rittman-Grauer, J. L. Biedler, J. R. Bertino, and M. R. Melamed. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA 86: 695-698, 1989.
6. Dallaire, L., L. Tremblay, and R. Béliveau. Purification and characterization of metabolically active capillaries of the blood-brain barrier. Biochem. J. 276: 745-752, 1991.
7. Dedon, P. C., and R. F. Borch. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles. Biochem. Pharmacol. 36: 1955-1964, 1987.
8. Demeule, M., Jodoin, J., Beaulieu, É., Brossard, M., and R. Béliveau. Dexamethasone modulation of multidrug transporters in normal tissues. FEBS Lett. 442: 208-214, 1999.
9. Evers, R., M. Kool, L. van Deemter, H. Janssen, J. Calafat, L. C. J. M. Oomen, C. C. Paulusma, R. P. J. Oude Elferink, F. Baas, A. H. Schinkel, and P. Borst. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (Mrp2) cDNA. J. Clin. Invest. 101: 1310-1319, 1998.
10. Fojo, A. T., K. Ueda, D. J. Slamon, D. G. Poplack, M. M. Gottesman, and I. Pastan. Expression of a multidrug resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA 84: 265-269, 1987.
11. George, S. G., and J. Kenny. Studies on the enzymology of purified preparations of brush border from rabbit kidney. Biochem. J. 134: 43-57, 1973.
12. Georges, E., F. J. Sharom, and V. Ling. Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy. Adv. Pharmacol. 21: 185-220, 1990.
13. Gordon, J. A., and V. H. Gattone II. Mitochondrial alterations in cisplatin-induced acute renal failure. Am. J. Physiol. 250 (Renal Fluid Electrolyte Physiol. 19): F991-F998, 1986.
14. Gottesman, M. M., and I. Pastan. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62: 385-427, 1993.
15. Hamaguchi, K., A. K. Godwin, M. Yakushiji, P. J. O'Dwyer, R. F. Ozols, and T. C. Hamilton. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. Cancer Res. 53: 5225-5232, 1993.
16. Ishikawa, T., and F. Ali-Osman. Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. J. Biol. Chem. 268: 20116-20125, 1993.
17. Ishikawa, T., M. Müller, C. Klünemann, T. Schaub, and D. Keppler. ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. J. Biol. Chem. 365: 19279-19286, 1990.
18. Ito, K., H. Suzuki, T. Hirohashi, K. Kume, T. Shimizu, and Y. Sugiyama. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am. J. Physiol. 272 (Gastrointest. Liver Physiol. 35): G16-G22, 1997.
19. Jetté, L., É. Beaulieu, J. M. Leclerc, and R. Béliveau. Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues. Am. J. Physiol. 270 (Renal Fluid Electrolyte Physiol. 39): F756-F765, 1996.
20. Kralovanszky, J., N. Prajda, S. Kerpel-Fronius, F. Gal, and F. Kiss. Comparison of intestinal toxic effects of platinum complexes: cisplatin (CDDP), carboplatin (CBDCA), and iproplatin (CHIP). Cancer Chemother. Pharmacol. 21: 40-44, 1988.
21. Kuhlmann, M. K., G. Burkhardt, and H. Köhler. Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol. Dial. Transplant. 12: 2478-2480, 1997.
22. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
23. Ling, V., N. Kartner, T. Sudo, L. Siminovitch, and J. R. Riordan. Multidrug-resistance phenotype in Chinese hamster ovary cells. Cancer Treat. Res. 67: 869-874, 1983.
24. -) with inherited conjugated hyperbilirubinemia. J. Clin. Invest. 90: 2130-2135, 1992.
25. Oguri, T., Y. Fujiwara, T. Isobe, O. Katoh, H. Watanabe, and M. Yamakido. Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs. Br. J. Cancer 77: 1089-1096, 1998.
26. Ohga, T., K. Koike, M. Ono, Y. Makino, Y. Itagaki, M. Tanimoto, M. Kuwano, and K. Kohno. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res. 56: 4224-4228, 1996.
27. Ohga, T., T. Uchiumi, Y. Makino, K. Koike, M. Wada, M. Kuwano, and K. Kohno. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J. Biol. Chem. 273: 5997-6000, 1998.
28. Ohishi, N., S. Imaoka, and Y. Funae. Changes in content of P-450 isozymes in hepatic and renal microsomes of the male rat treated with cis-diamminedichloroplatinum. Xenobiotica 24: 873-880, 1994.
29. Paulusma, C. C., M. Kool, P. J. Bosma, G. L. Scheffer, F., ter Borg, R. J. Scheper, G. N. Tytgat, P. Borst, F. Baas, and R. P. J. Oude Elferink. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 25: 1539-1542, 1997.
30. Schaub, T. P., J. Kartenbeck, J. König, O. Vogel, R. Witzgall, W. Kriz, and D. Keppler. Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. Am. J. Soc. Nephrol. 8: 1213-1221, 1997.
31. Schinkel, A. H., J. J. M. Smit, O. van Tellingen, J. H. Eeijnen, E. Wagenaar, L. van Deemter, C. A. A. M. Mol, M. A. van der Valk, E. C. Robanus-Maandag, H. P. J. te Riele, A. J. M. Berns, and P. Borst. Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77: 491-502, 1994.
32. Siddik, Z. H., S. E. Dible, F. E. Boxall, and K. R. Harrap. Renal pharmacokinetics and toxicity of cisplatin and carboplatin in animals. In: Biochemical Mechanisms of Platinum Antitumor Drugs, edited by D. C. H. McBrien and T. F. Slater. Oxford, UK: IRL, 1986, p. 171-198.
33. Singh, G. A possible cellular mechanism of cisplatin-induced nephrotoxicity. Toxicology 58: 71-80, 1989.
34. Stein, J. H., M. D. Lifschitz, and L. D. Barnes. Current concepts on the nephrotoxicity of acute renal failure. Am. J. Physiol. 243 (Renal Fluid Electrolyte Physiol. 12): F171-F181, 1982.
35. Taniguchi, K., M. Wada, K. Kohno, T. Nakamura, T. Kawabe, M. Kawakami, K. Kagotani, K. Okumura, S. Akiyama, and M. Kuwano. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer lines with decreased drug accumulation. Cancer Res. 56: 4124-4129, 1996.
36. Trauner, M., M. Arrese, C. J. Soroka, M. Ananthanarayanan, T. A. Koeppel, S. F. Schlosser, F. J. Suchy, D. Keppler, and J. L. Boyer. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 113: 255-264, 1997.
37. Vickers, A. E. M., M. Alegret, E. Meyer, S. Smiley, and J. Guertler. Hydroxyethyl cyclosporin A induces and decreases P-4503A and P-glycoprotein levels in rat liver. Xenobiotica 26: 27-39, 1996.
38. Vos, T. A., G. J. Hooiveld, H. Koning, S. Childs, D. K. Meijer, H. Moshage, P. L. Jansen, and M. Müller. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2 and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 28: 1637-1644, 1998.
39. Wacher, V. J., C. Y. Wu, and L. Z. Benet. Overlapping substrate specificities and tissue distribution of cytochrome P-450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol. Carcinog. 13: 129-134, 1995.